Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.
346 questions in 59 reviews · Vascular
current versionsNo studies 346 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Intervention NR Death from bleeding complications (up to 30 days · vascular surgery patients who undergo creation of an anastomosis The role of sealants for achieving anastomotic hemostasis in vascular surgery (2024) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Change in claudication distance from baseline (m) · people with intermittent claudication Mobile health technologies to improve walking distance in people with intermittent claudication (2024) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Amputation‐free survival · people with intermittent claudication Mobile health technologies to improve walking distance in people with intermittent claudication (2024) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Revascularisation‐free survival · people with intermittent claudication Mobile health technologies to improve walking distance in people with intermittent claudication (2024) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Major adverse limb events (MALE) · people with intermittent claudication Mobile health technologies to improve walking distance in people with intermittent claudication (2024) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Above‐ankle amputation · people with intermittent claudication Mobile health technologies to improve walking distance in people with intermittent claudication (2024) · Cochrane | no estimate extracted | NR | No studies |
Physical exercise vs no treatment Incidence of venous leg ulcer · people with non‐ulcerated chronic venous insufficiency Physical exercise for the treatment of non‐ulcerated chronic venous insufficiency (2023) · Cochrane | no estimate extracted | NR | No studies |
Oral factor Xa inhibitors vs conventional anticoagulation Health‐related quality of life · people with a pulmonary embolism, confirmed by standard imaging techniques Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the… (2023) · Cochrane | no estimate extracted | NR | No studies |
Oral direct thrombin inhibitors (DTIs) vs conventional anticoagulation All‐cause mortality · people with a pulmonary embolism, confirmed by standard imaging techniques Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the… (2023) · Cochrane | no estimate extracted | NR | No studies |
Oral direct thrombin inhibitors (DTIs) vs conventional anticoagulation Health‐related quality of life · people with a pulmonary embolism, confirmed by standard imaging techniques Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the… (2023) · Cochrane | no estimate extracted | NR | No studies |
Balneotherapy vs melilotus officinalis Adverse effects of treatment · people with chronic venous insufficiency Balneotherapy for chronic venous insufficiency (2023) · Cochrane | no estimate extracted | NR | No studies |
Balneotherapy vs melilotus officinalis Incidence of leg ulcer · people with chronic venous insufficiency Balneotherapy for chronic venous insufficiency (2023) · Cochrane | no estimate extracted | NR | No studies |
Balneotherapy vs melilotus officinalis Skin pigmentation changes · people with chronic venous insufficiency Balneotherapy for chronic venous insufficiency (2023) · Cochrane | no estimate extracted | NR | No studies |
Balneotherapy vs dryland exercise Disease severity signs and symptoms score · people with chronic venous insufficiency Balneotherapy for chronic venous insufficiency (2023) · Cochrane | no estimate extracted | NR | No studies |
Balneotherapy vs dryland exercise Adverse effects of treatment · people with chronic venous insufficiency Balneotherapy for chronic venous insufficiency (2023) · Cochrane | no estimate extracted | NR | No studies |
Balneotherapy vs dryland exercise Pain · people with chronic venous insufficiency Balneotherapy for chronic venous insufficiency (2023) · Cochrane | no estimate extracted | NR | No studies |
Balneotherapy vs dryland exercise Incidence of leg ulcer · people with chronic venous insufficiency Balneotherapy for chronic venous insufficiency (2023) · Cochrane | no estimate extracted | NR | No studies |
Balneotherapy vs dryland exercise Skin pigmentation changes · people with chronic venous insufficiency Balneotherapy for chronic venous insufficiency (2023) · Cochrane | no estimate extracted | NR | No studies |
Balneotherapy vs melilotus officinalis Disease severity signs and symptoms score · people with chronic venous insufficiency Balneotherapy for chronic venous insufficiency (2023) · Cochrane | no estimate extracted | NR | No studies |
Balneotherapy vs melilotus officinalis Health‐related quality of life · people with chronic venous insufficiency Balneotherapy for chronic venous insufficiency (2023) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings: Tranexamic acid vs placebo Red cell transfusions (units per participant) up to 30 days post surgery · people aged 18 and over undergoing vascular surgery Drugs to reduce bleeding and transfusion in major open vascular or endovascular surgery: a systematic review… (2023) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings: Fibrin sealant vs usual care Red cell transfusions (units per participant) up to 30 days post surgery · people aged 18 and over undergoing vascular surgery Drugs to reduce bleeding and transfusion in major open vascular or endovascular surgery: a systematic review… (2023) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings: Fibrin sealant vs usual care Risk of receiving any allogeneic blood product up to 30 days · people aged 18 and over undergoing vascular surgery Drugs to reduce bleeding and transfusion in major open vascular or endovascular surgery: a systematic review… (2023) · Cochrane | no estimate extracted | NR | No studies |
Gait training protocol focused on impairment level vs gait training protocol focused on task level Quality of life · people with transtibial amputation due to peripheral arterial disease or diabetes Interventions for motor rehabilitation in people with transtibial amputation due to peripheral arterial… (2023) · Cochrane | no estimate extracted | NR | No studies |
Gait training protocol focused on impairment level vs gait training protocol focused on task level Phantom limb pain frequency · people with transtibial amputation due to peripheral arterial disease or diabetes Interventions for motor rehabilitation in people with transtibial amputation due to peripheral arterial… (2023) · Cochrane | no estimate extracted | NR | No studies |
Motor imaging vs usual care Adverse events · people with transtibial amputation due to peripheral arterial disease or diabetes Interventions for motor rehabilitation in people with transtibial amputation due to peripheral arterial… (2023) · Cochrane | no estimate extracted | NR | No studies |
Motor imaging vs usual care Mortality – all causes · people with transtibial amputation due to peripheral arterial disease or diabetes Interventions for motor rehabilitation in people with transtibial amputation due to peripheral arterial… (2023) · Cochrane | no estimate extracted | NR | No studies |
Motor imaging vs usual care Quality of life · people with transtibial amputation due to peripheral arterial disease or diabetes Interventions for motor rehabilitation in people with transtibial amputation due to peripheral arterial… (2023) · Cochrane | no estimate extracted | NR | No studies |
Motor imaging vs usual care Phantom limb pain frequency · people with transtibial amputation due to peripheral arterial disease or diabetes Interventions for motor rehabilitation in people with transtibial amputation due to peripheral arterial… (2023) · Cochrane | no estimate extracted | NR | No studies |
Gait training protocol focused on impairment level vs gait training protocol focused on task level Mortality – all cause · people with transtibial amputation due to peripheral arterial disease or diabetes Interventions for motor rehabilitation in people with transtibial amputation due to peripheral arterial… (2023) · Cochrane | no estimate extracted | NR | No studies |
Duplex ultrasound plus pulse palpation and arterial pressure index (ABI or TBI) vs pulse palpation plus arterial pressure index (ABI or TBI) (long term) Adverse events resulting from DUS surveillance · people who underwent a lower limb revascularisation Duplex ultrasound for surveillance of lower limb revascularisation (2023) · Cochrane | no estimate extracted | NR | No studies |
Duplex ultrasound plus pulse palpation and arterial pressure index (ABI or TBI) vs pulse palpation plus arterial pressure index (ABI or TBI) (long term) All‐cause mortality · people who underwent a lower limb revascularisation Duplex ultrasound for surveillance of lower limb revascularisation (2023) · Cochrane | no estimate extracted | NR | No studies |
Duplex ultrasound plus pulse palpation and arterial pressure index (ABI or TBI) vs pulse palpation plus arterial pressure index (ABI or TBI) (long term) Functional walking ability · people who underwent a lower limb revascularisation Duplex ultrasound for surveillance of lower limb revascularisation (2023) · Cochrane | no estimate extracted | NR | No studies |
Duplex ultrasound plus pulse palpation and arterial pressure index (ABI or TBI) vs pulse palpation plus arterial pressure index (ABI or TBI) (long term) Clinical severity scales · people who underwent a lower limb revascularisation Duplex ultrasound for surveillance of lower limb revascularisation (2023) · Cochrane | no estimate extracted | NR | No studies |
Duplex ultrasound plus pulse palpation and arterial pressure index (ABI or TBI) vs pulse palpation plus arterial pressure index (ABI or TBI) (long term) Quality of life scores · people who underwent a lower limb revascularisation Duplex ultrasound for surveillance of lower limb revascularisation (2023) · Cochrane | no estimate extracted | NR | No studies |
Duplex ultrasound plus pulse palpation and arterial pressure index (ABI or TBI) vs pulse palpation plus arterial pressure index (ABI or TBI) (short term) Adverse events resulting from DUS surveillance · people who underwent a lower limb revascularisation Duplex ultrasound for surveillance of lower limb revascularisation (2023) · Cochrane | no estimate extracted | NR | No studies |
Duplex ultrasound plus pulse palpation and arterial pressure index (ABI or TBI) vs pulse palpation plus arterial pressure index (ABI or TBI) (short term) Functional walking ability · people who underwent a lower limb revascularisation Duplex ultrasound for surveillance of lower limb revascularisation (2023) · Cochrane | no estimate extracted | NR | No studies |
Duplex ultrasound plus pulse palpation and arterial pressure index (ABI or TBI) vs pulse palpation plus arterial pressure index (ABI or TBI) (short term) Clinical severity scales · people who underwent a lower limb revascularisation Duplex ultrasound for surveillance of lower limb revascularisation (2023) · Cochrane | no estimate extracted | NR | No studies |
Duplex ultrasound plus pulse palpation and arterial pressure index (ABI or TBI) vs pulse palpation plus arterial pressure index (ABI or TBI) (long term) Limb salvage rate · people who underwent a lower limb revascularisation Duplex ultrasound for surveillance of lower limb revascularisation (2023) · Cochrane | no estimate extracted | NR | No studies |
Primary treatment with intravenous immunoglobulin (IVIG) vs different infusion regimens of IVIG Acute coronary syndrome (such as MI or coronary thrombus) (up to 7 weeks) · people undergoing initial treatment for KD Intravenous immunoglobulin for the treatment of Kawasaki disease (2023) · Cochrane | no estimate extracted | NR | No studies |
Primary treatment with intravenous immunoglobulin (IVIG) vs prednisolone Need for additional treatment · people undergoing initial treatment for KD Intravenous immunoglobulin for the treatment of Kawasaki disease (2023) · Cochrane | no estimate extracted | NR | No studies |
Primary treatment with intravenous immunoglobulin (IVIG) vs prednisolone Length of hospital stay (days) · people undergoing initial treatment for KD Intravenous immunoglobulin for the treatment of Kawasaki disease (2023) · Cochrane | no estimate extracted | NR | No studies |
Primary treatment with intravenous immunoglobulin (IVIG) vs acetylsalicylic acid (ASA) Length of hospital stay (days) · people undergoing initial treatment for KD Intravenous immunoglobulin for the treatment of Kawasaki disease (2023) · Cochrane | no estimate extracted | NR | No studies |
Anticoagulant vs different dose of the same anticoagulant Deep vein thrombosis · non‐hospitalised people with COVID‐19 Prophylactic anticoagulants for non‐hospitalised people with COVID‐19 (2023) · Cochrane | no estimate extracted | NR | No studies |
Anticoagulant vs different dose of the same anticoagulant Pulmonary embolism · non‐hospitalised people with COVID‐19 Prophylactic anticoagulants for non‐hospitalised people with COVID‐19 (2023) · Cochrane | no estimate extracted | NR | No studies |
Anticoagulant vs antiplatelet agent Deep vein thrombosis · non‐hospitalised people with COVID‐19 Prophylactic anticoagulants for non‐hospitalised people with COVID‐19 (2023) · Cochrane | no estimate extracted | NR | No studies |
Anticoagulant vs antiplatelet agent Pulmonary embolism · non‐hospitalised people with COVID‐19 Prophylactic anticoagulants for non‐hospitalised people with COVID‐19 (2023) · Cochrane | no estimate extracted | NR | No studies |
Intramuscular injection of bone marrow mononuclear cells (BMMNC) vs control Angiographic analysis · people with CLI who were not suitable for revascularisation and showed no improvement in response to the best standard… Local intramuscular transplantation of autologous bone marrow mononuclear cells for critical lower limb… (2022) · Cochrane | no estimate extracted | NR | No studies |
Corticosteroids vs no corticosteroid use Longer term (> 1 year after disease onset) coronary morbidity (non‐aneurysmal) · children diagnosed with Kawasaki disease Corticosteroids for the treatment of Kawasaki disease in children (2022) · Cochrane | no estimate extracted | NR | No studies |
Chronic DVT ‐ antiplatelet agents plus BMP vs BMP alone Post‐thrombotic syndrome · people requiring treatment for chronic DVT Antiplatelet agents for the treatment of deep venous thrombosis (2022) · Cochrane | no estimate extracted | NR | No studies |